Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
20.47
0.00 (0.00%)
At close: Feb 27, 2026, 4:00 PM EST
20.54
+0.07 (0.34%)
After-hours: Feb 27, 2026, 4:10 PM EST
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of $335.46 million as of February 27, 2026. Its market cap has increased by 152.68% in one year.
Market Cap
335.46M
Enterprise Value
185.52M
1-Year Change
152.68%
Ranking
Category
Stock Price
$20.47
Market Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has decreased from $346.92M to $335.46M, a decrease of -3.30%. That is a compound annual growth rate of -0.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 335.46M | 240.33% |
| Dec 31, 2025 | 98.57M | -35.03% |
| Dec 31, 2024 | 151.72M | -41.98% |
| Dec 29, 2023 | 261.49M | -43.69% |
| Dec 30, 2022 | 464.40M | -32.55% |
| Dec 31, 2021 | 688.50M | -30.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aclaris Therapeutics | 358.62M |
| Adlai Nortye | 358.30M |
| Foghorn Therapeutics | 339.77M |
| Climb Bio | 338.51M |
| Immuneering | 338.35M |
| Cabaletta Bio | 335.97M |
| Relmada Therapeutics | 333.67M |
| XOMA Royalty | 331.12M |